$VTIX

Virtuix Holdings (VTIX) received a notice from Nasdaq on September 30, 2026, stating it no longer meets the $50 million market value requirement or the alternative standard. The company has until March 29, 2027, to regain compliance or face potential delisting, with the option to transfer to the Nasdaq Capital Market.

Virtuix Holdings reported Omni One orders are 3X higher year-over-year since its June launch, with increased U.S. government and enterprise demand. The company did not provide specific revenue figures.

Virtuix Holdings Inc. (VTIX) filed an SEC Form 8-K — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. On September 29, 2026, the Board of Directors (the “Board”) of Virtuix Holdings Inc. (the “Company”) approved a supplement

Virtuix (VTIX) announced its Omni One for Quest content library has expanded to 75+ games, following a 3X increase in orders since June. Meta's new VR glasses, weighing 100g, may support Omni One. The company sees strong momentum in VR ecosystem growth, with Meta and Valve's innovations driving demand.

Virtuix (VTIX) reported a 3X increase in Omni One orders quarter-to-date, driven by its collaboration with Meta. The company also highlighted progress in defense programs, enterprise sales to Tesla and NASA, and a potential acquisition. VTIX stock rose 0.94% following the news.

Virtuix (VTIX) sold its Omni One systems to the U.S. Department of Veterans Affairs for deployment at the Detroit VA Medical Center. The systems will be evaluated for therapeutic applications and potential use in the VA's nationwide 'VA Immersive' network, which spans over 145 facilities. This sale marks Virtuix's expansion into veteran healthcare and could support wider adoption of its technology.

Virtuix (VTIX) sold Omni One systems to the U.S. Department of Veterans Affairs for deployment at the Detroit VA Medical Center. This marks the company's entry into the VA's healthcare system, which spans over 145 facilities. The sale could represent a significant long-term opportunity for Virtuix's technology in therapeutic applications.

Emerging Growth Research reiterated its Buy-Emerging rating and $9.00 price target for Virtuix (VTIX), citing strong fiscal 2026 results and growth prospects. The company reported 32% sequential revenue growth in Q4 2026, with forecasts of 15% and 290% revenue growth for fiscal 2027 and 2028, respectively. Virtuix launched Omni One for Quest, expanding its market to Meta Quest users, and continues to pursue defense opportunities.

Virtuix Holdings Inc. (VTIX) announced its CEO will present at the H.C. Wainwright conference, highlighting recent momentum and Omni One expansion. The company reported quarterly revenue over 50% above analyst estimates, with growing demand in defense, robotics, healthcare, and enterprise markets.

Virtuix Holdings Inc. sold its first Omni One Enterprise systems to the U.S. Navy's Morale, Welfare and Recreation Liberty Program. The two units, priced at around $15,000 each, will be deployed at a U.S. Naval Station in Europe. This sale could lead to further deployments if successful, as the program has 68 locations globally.